Join the club for FREE to access the whole archive and other member benefits.

Danny Sullivan

Contributing editor to Longevity Technology

Danny has worked in technology communications for more than 15 years, spanning Europe and North America. From bionics and lasers to software and pharmaceuticals – and everything in between – he’s covered it all. Danny has wide experience of technology publishing and technical writing and has specific interest in the transfer from idea to market.

Details last updated 10-Feb-2020

Articles written by Danny Sullivan

Cyclana Bio: redefining women’s health

Cyclana Bio: redefining women’s health

Longevity Technology - 30-Oct-2025

Using menstrual fluid, Cyclana builds tissue models to tackle endometriosis and chronic inflammation

Mission raises $13.3m for Parkinson’s mitophagy drug

Mission raises $13.3m for Parkinson’s mitophagy drug

Longevity Technology - 27-Oct-2025

Cambridge biotech to trial USP30 inhibitor MTX325 to boost mitochondrial repair in Parkinson’s

Elevara raises $70M to tackle rheumatoid arthritis

Elevara raises $70M to tackle rheumatoid arthritis

Longevity Technology - 23-Oct-2025

Biotech startup Elevara aims to transform RA treatment with a non-immunosuppressive oral drug

Eli Lilly backs NewLimit’s $45m push toward cellular rejuvenation

Eli Lilly backs NewLimit’s $45m push toward cellular rejuvenation

Longevity Technology - 21-Oct-2025

NewLimit’s $45M raise advances youthful liver and immune cell restoration in preclinical studies

Pelage secures $120M to advance stem cell hair loss therapy

Pelage secures $120M to advance stem cell hair loss therapy

Longevity Technology - 17-Oct-2025

PP405 shows early promise in reactivating dormant hair follicles to restore growth

Kneu Health created an AI-powered phone app to detect early signs of brain decline

Kneu Health created an AI-powered phone app to detect early signs of brain decline

Longevity Technology - 09-Oct-2025

Trials showed fewer hospital visits and faster access to care

AI meets CRISPR: Algen and AstraZeneca join forces in $555m gene discovery deal

AI meets CRISPR: Algen and AstraZeneca join forces in $555m gene discovery deal

Longevity Technology - 06-Oct-2025

Partnership aims to uncover disease-driving genes and boost precision drug development

Gene therapy startup aims to reverse retinal aging to restore vision

Gene therapy startup aims to reverse retinal aging to restore vision

Longevity Technology - 03-Oct-2025

Cirrus Therapeutics targets aging biology to combat blindness from dry AMD

Until Labs raises $58M to push boundaries of cryopreservation

Until Labs raises $58M to push boundaries of cryopreservation

Longevity Technology - 23-Sep-2025

Startup scaled cryopreservation from neural slices to large-animal organs, eyeing human trials

Bio Protocol raises $6.9M to scale AI-native DeSci biotech platform

Bio Protocol raises $6.9M to scale AI-native DeSci biotech platform

Longevity Technology - 19-Sep-2025

First BioAgent generated 1,000+ hypotheses, raised $900K, and drove lab testing within weeks

K-dense AI accelerates ageing research

K-dense AI accelerates ageing research

Longevity Technology - 18-Sep-2025

New multi-agent AI analyzes massive datasets to predict biological age in weeks, not years

Revalia Bio raises $14.5M to advance human organ-based drug testing

Revalia Bio raises $14.5M to advance human organ-based drug testing

Longevity Technology - 09-Sep-2025

Using donated organs, Revalia aims to cut drug failures and speed safe treatments to patients

NRG raises $67M for mitochondrial drugs in neurodegeneration

NRG raises $67M for mitochondrial drugs in neurodegeneration

Longevity Technology - 08-Sep-2025

Funding backs trials of NRG5051, aiming to slow ALS and Parkinson’s by protecting neurons

Novartis, Arrowhead sign $2b deal for Parkinson’s RNA therapy

Novartis, Arrowhead sign $2b deal for Parkinson’s RNA therapy

Longevity Technology - 02-Sep-2025

Experimental RNAi drug aims to silence alpha-synuclein and slow neurodegeneration

Minovia powers up mitochondrial medicine

Minovia powers up mitochondrial medicine

Longevity Technology - 01-Sep-2025

$350K grant fuels Minovia’s biomarker work, as early trials show promising patient gains

Debut raises $20M to pioneer AI-driven skin longevity ingredients

Debut raises $20M to pioneer AI-driven skin longevity ingredients

Longevity Technology - 28-Aug-2025

Startup uses AI to explore billions of molecules for next-gen skincare innovation

OneSkin raises $20M to boost skin longevity science

OneSkin raises $20M to boost skin longevity science

Longevity Technology - 08-Aug-2025

New funding will help expand OneSkin’s reach and target ageing at the cellular level

Sava raises $19m for next-gen glucose monitoring wearable

Sava raises $19m for next-gen glucose monitoring wearable

Longevity Technology - 31-Jul-2025

With $19 million funding, the startup plans regulatory approvals and scaling

Immortal Dragons has launched with $40 million to support longevity research

Immortal Dragons has launched with $40 million to support longevity research

Longevity Technology - 18-Jul-2025

The fund bridges East-West collaboration and acts quickly using its own capital

Mito Fund invests in Pretzel Therapeutics for mitochondrial disease therapies

Mito Fund invests in Pretzel Therapeutics for mitochondrial disease therapies

Longevity Technology - 15-Jul-2025

New investment fuels development of therapies targeting mtDNA-related energy disorders


Display all articles